Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IGTE
3426
DELISTED
IGATE CORPORATION
IGTE
| $890K | ﹤0.01% |
32,954
+7,575
| +30% | +$173K |
|
|
MDC
3427
DELISTED
M.D.C. Holdings, Inc.
MDC
| $889K | ﹤0.01% |
41,144
-23,803
| -37% | -$524K |
|
3428
CALL
Advance Auto Parts
AAP
$3.49B
| $886K | ﹤0.01% |
10,800
-1,400
| -11% | -$114K |
|
|
ZQK
3429
PUT
DELISTED
QUICKSILVER,INC.
ZQK
| $886K | ﹤0.01% |
126,600
-51,200
| -29% | -$320K |
|
3430
Brink's
BCO
$4.62B
| $885K | ﹤0.01% |
31,629
+423
| +1% | +$11.5K |
|
3431
Unilever
UL
$136B
| $883K | ﹤0.01% |
20,645
+13,176
| +176% | +$598K |
|
3432
Northwest Bancshares
NWBI
$2.28B
| $882K | ﹤0.01% |
67,900
-42,678
| -39% | -$588K |
|
|
VTA
3433
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
| $881K | ﹤0.01% |
73,462
+30,799
| +72% | +$393K |
|
|
MINI
3434
DELISTED
Mobile Mini Inc
MINI
| $880K | ﹤0.01% |
25,881
-3,131
| -11% | -$103K |
|
3435
PUT
Popular Inc
BPOP
$11.1B
| $879K | ﹤0.01% |
33,800
+18,900
| +127% | +$595K |
|
3436
BWX Technologies
BWXT
$15.6B
| $879K | ﹤0.01% |
37,262
-154
| -0.4% | -$3.49K |
|
3437
ON Semiconductor
ON
$31.6B
| $879K | ﹤0.01% |
125,616
+61,917
| +97% | +$475K |
|
3438
Adeia
ADEA
$3.11B
| $878K | ﹤0.01% |
174,768
-76,976
| -31% | -$407K |
|
3439
First Financial Bankshares
FFIN
$4.97B
| $878K | ﹤0.01% |
60,572
-32,876
| -35% | -$490K |
|
3440
Nordson
NDSN
$17.3B
| $878K | ﹤0.01% |
12,034
-5,555
| -32% | -$399K |
|
3441
Idexx Laboratories
IDXX
$46.2B
| $876K | ﹤0.01% |
17,714
+2,322
| +15% | +$112K |
|
|
AVNR
3442
CALL
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $876K | ﹤0.01% |
219,100
+216,000
| +6,968% | +$1.02M |
|
3443
CALL
Hovnanian Enterprises
HOV
$807M
| $873K | ﹤0.01% |
6,984
-1,988
| -22% | -$266K |
|
3444
CALL
Prologis
PLD
$133B
| $873K | ﹤0.01% |
23,600
-60,600
| -72% | -$2.28M |
|
3445
CALL
ProShares Ultra Materials
UYM
$40.9M
| $873K | ﹤0.01% |
85,200
+4,800
| +6% | +$47.1K |
|
|
GLBR
3446
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
| $872K | ﹤0.01% |
4,586
+50
| +1% | +$9K |
|
3447
CALL
Oxford Industries
OXM
$552M
| $871K | ﹤0.01% |
13,000
-6,700
| -34% | -$443K |
|
|
CLVS
3448
DELISTED
Clovis Oncology, Inc.
CLVS
| $871K | ﹤0.01% |
14,519
+12,605
| +659% | +$894K |
|
3449
CALL
Manitowoc
MTW
$675M
| $870K | ﹤0.01% |
50,561
+2,539
| +5% | +$46.1K |
|
3450
Texas Capital Bancshares
TCBI
$4.32B
| $870K | ﹤0.01% |
19,328
-10,300
| -35% | -$474K |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.